首页> 外文期刊>Journal of chromatography, B. Analytical technologies in the biomedical and life sciences >Simultaneous quantification of beclomethasone dipropionate and its metabolite, beclomethasone 17-monopropionate in rat and human plasma and different rat tissues by liquid chromatography–positive electrospray ionization tandem mass spectrometry
【24h】

Simultaneous quantification of beclomethasone dipropionate and its metabolite, beclomethasone 17-monopropionate in rat and human plasma and different rat tissues by liquid chromatography–positive electrospray ionization tandem mass spectrometry

机译:液相色谱-正电喷雾电离串联质谱法同时定量测定大鼠和人血浆及不同大鼠组织中的倍氯米松二丙酸酯及其代谢产物倍氯米松17-单丙酸酯

获取原文
获取原文并翻译 | 示例
       

摘要

A sensitive, rapid and selective liquid chromatography–positive electrospray ionization tandem mass spectrometry (LC–(ESI+)-MS–MS) method has been developed and validated for the simultaneous quantification of beclomethasone dipropionate (BDP) and its active metabolite, beclomethasone 17-monopropionate (17-BMP) in rat plasma and different tissues using fluticasone propionate (FP) as the internal standard. The method was validated over a linear range from 0.05 to 5 ng/ml for both analytes. A solid-phase extraction procedure was used for plasma samples and a liquid–liquid extraction procedure for tissues samples (lung, liver and kidney). The between-day and within-day coefficients of variation for all compounds were ≤20% at the concentrations of lower limit of quantification (LLOQ) and ≤15% at other quality control concentrations. The same method was also partially validated for human plasma. The utility of this assay was demonstrated by monitoring BDP and 17-BMP plasma and tissue concentrations in an animal study designed for evaluation of pulmonary targeting after intratracheal administration of BDP dry powder.
机译:一种灵敏,快速且选择性的液相色谱-正电喷雾电离串联质谱法(LC-(ESI +)-MS-MS)已开发并验证了同时定量倍氯米松二丙酸酯(BDP)及其活性代谢物倍氯米松17-使用丙酸氟替卡松(FP)作为内标在大鼠血浆和不同组织中的单丙酸酯(17-BMP)。对于两种分析物,该方法均在0.05至5 ng / ml的线性范围内得到验证。固相萃取程序用于血浆样品,液液萃取程序用于组织样品(肺,肝和肾)。所有化合物的日间和日内变异系数在定量下限(LLOQ)浓度下≤20%,在其他质量控制浓度下≤15%。相同的方法也已部分验证了人体血浆。通过在动物研究中监测BDP和17-BMP血浆和组织浓度来证明该测定法的实用性,该研究旨在评估气管内施用BDP干粉后的肺靶向性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号